5 research outputs found
PREPARATION AND EVALUATION OF TUSCAN SAUSAGE OF CHICKEN MEAT WITH THE ADDITION OF QUINOA
The meat has exceptional organoleptic characteristics associated with its nutritional value, convert it into a food of animal origin most valued by consumers. Due to the lack of time to eat properly, people started to consume more frequently, manufactured products, fried foods, sweets and sandwiches, disregarding the negative factors to health. Aiming at the need to prepare food with low cholesterol levels, this study aimed to prepare and study the sensory acceptance of Tuscan sausage of chicken meat with the addition of quinoa. The practice of preparing formulations followed the standard procedure for the preparation of sausage from Tuscany using gut collagen and 3.0 % of quinoa. The samples were analyzed for protein (g 100g-1), fat (g100g-1), moisture content (g 100g-1), caloric value (kcal/g) and sensory analyses. The results of microbiological and physicochemical were within normal limits required by law, qualifying products made fit for human consumption. A sensory acceptance test was carried out with 30 untrained panelists. The marks awarded by the panelists for the color, juiciness, odor flavor, texture and overall acceptance attributes were between 4 (Moderately Good) and 5 (Very Good), indicating that formulations are within the zone of acceptance. The marks awarded by the judges for the purchase of attitude corresponds to "Certainly Buy", showing that this product can be marketed
PREPARATION AND EVALUATION OF TUSCAN SAUSAGE OF CHICKEN MEAT WITH THE ADDITION OF QUINOA
The meat has exceptional organoleptic characteristics associated with its nutritional value, convert it into a food of animal origin most valued by consumers. Due to the lack of time to eat properly, people started to consume more frequently, manufactured products, fried foods, sweets and sandwiches, disregarding the negative factors to health. Aiming at the need to prepare food with low cholesterol levels, this study aimed to prepare and study the sensory acceptance of Tuscan sausage of chicken meat with the addition of quinoa. The practice of preparing formulations followed the standard procedure for the preparation of sausage from Tuscany using gut collagen and 3.0 % of quinoa. The samples were analyzed for protein (g 100g-1), fat (g100g-1), moisture content (g 100g-1), caloric value (kcal/g) and sensory analyses. The results of microbiological and physicochemical were within normal limits required by law, qualifying products made fit for human consumption. A sensory acceptance test was carried out with 30 untrained panelists. The marks awarded by the panelists for the color, juiciness, odor flavor, texture and overall acceptance attributes were between 4 (Moderately Good) and 5 (Very Good), indicating that formulations are within the zone of acceptance. The marks awarded by the judges for the purchase of attitude corresponds to "Certainly Buy", showing that this product can be marketed
Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study
Background and aim: Elevated triglyceride (TG) levels seem to identify subjects at increased cardiovascular risk, independent of LDL-C levels. We sought to evaluate the predictive role of hypertriglyceridemia, defined as TG levels ≥150 mg/dl, in very high risk (VHR) patients with chronic coronary syndromes (CCS) treated with statins. Methods and results: Using the data from the STable Coronary Artery Diseases RegisTry (START) study, an Italian nationwide registry, we assessed the association between the TG levels and baseline clinical characteristics, pharmacological treatment and major adverse cardio-cerebrovascular events (MACCE) at 1 year in a large cohort of statin-treated patients at VHR. Of the 4751 consecutive patients with CCS enrolled in the registry and classified as VHR, 2652 (55.8%) had TG values available (mean 120.6 ± 54.9) and were treated with at least a statin at baseline: 2019 (76.1%) with TG < 150 and 633 (23.9%) with TG ≥ 150 mg/dl. At 1 year from enrolment, MACCE occurred in 168 (6.3%) patients, without differences between the two groups of TG (5.9 vs 7.6%; p = 0.14). At multivariable analysis, hypertriglyceridemia did not result as independent predictor of the MACCE (hazard ratio: 1.16; 95% confidence intervals: 0.82–1.64; p = 0.42). Conclusions: In the present large, nationwide cohort of consecutive CCS patients at VHR with statin-controlled LDL-C levels, hypertriglyceridemia was present in around 24% of cases and did not result as predictor of MACCE at 1 year. Further studies with a longer follow-up and larger sample size are needed to better define the prognostic role of TG levels when intensive LDL lowering therapies are used
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry
Aims Recently, the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial demonstrated that dual therapy reduced cardiovascular outcomes compared with aspirin alone in patients with stable atherosclerotic disease. Methods and We sought to assess the proportion of patients eligible for the COMPASS trial and to compare the epidemiology results and outcome of these patients with those without COMPASS inclusion or with any exclusion criteria in a contemporary, nationwide cohort of patients with stable coronary artery disease. Among the 4068 patients with detailed information allowing evaluation of eligibility, 1416 (34.8%) did not fulfil the inclusion criteria (COMPASS-Not-Included), 841 (20.7%) had exclusion criteria (COMPASS-Excluded), and the remaining 1811 (44.5%) were classified as COMPASS-Like. At 1 year, the incidence of major adverse cardiovascular event (MACE), a composite of cardiovascular death, myocardial infarction, and stroke, was 0.9% in the COMPASS-Not-Included and 2.0% in the COMPASS-Like (P = 0.01), and 5.0% in the COMPASS-Excluded group (P < 0.0001 for all comparisons). Among the COMPASS-Like population, patients with multiple COMPASS enrichment criteria presented a significant increase in the risk of MACE (from 1.0% to 3.3% in those with 1 and >_3 criteria, respectively; P = 0.012), and a modest absolute increase in major bleeding risk (from 0.2% to 0.4%, respectively; P = 0.46). Conclusion In a contemporary real-world cohort registry of stable coronary artery disease, most patients resulted as eligible for the COMPASS. These patients presented a considerable annual risk of MACE that consistently increases in the presence of multiple risk factors
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study
Aims: We evaluated the 1-year clinical events, pharmacological management, and quality of life in a contemporary cohort of stable coronary artery disease (CAD) patients managed by cardiologists. Methods and results: START (STable Coronary Artery Diseases RegisTry) was a prospective, observational, nationwide study that enrolled 5070 stable CAD patients over 3 months in 183 cardiology centres in Italy. At 1 year, 4790 (94.5%) patients had data on vital status. Death occurred in 107 (2.2%) patients and the cause of death was cardiovascular in 41 (38.3%) of cases. Among the 4775 patients with follow-up data on clinical events available, a hospitalization due to cardiovascular and non-cardiovascular causes occurred in 523 (11.0%) and in 231 (4.8%) of cases, respectively. Over 60% of patients reported as 'no problems' in all domains (61.4-84.5%) of the EuroQoL quality of life 5D-5L questionnaire. Among the 3239 patients with clinical visit/telephone interview at follow-up, in whom optimal medical therapy (OMT; aspirin or thienopyridine, β-blocker, and statin) was prescribed at enrolment, 2971 (91.7%) were still receiving OMT at follow-up. At multivariable analysis, only increasing age (odds ratio 0.98; 95% confidence interval 0.97-0.99; P = 0.04) resulted as independent negative predictor of OMT persistence at 1 year from enrolment. Conclusion: In this large, contemporary registry, stable CAD patients managed by cardiologists presented a high rate of clinical events at 1 year. Nevertheless, the persistence to OMT and quality of life appeared reasonable